- Former LBBC staff writer and content coordinator
Pembrolizumab approved for high-risk triple-negative breast cancer
The FDA approved the use of pembrolizumab (Keytruda) to treat some early-stage, triple-negative breast cancers, marking the first time an immunotherapy medicine has been approved for use in early-stage breast cancer.
Healthy eating habits you can start right now
There are many ways to make healthier food choices, but it can be hard to know where to start. We spoke to cancer nutrition and fitness expert Stacy Kennedy, MPH, RD, CSO, LDN, CPT, about what you can do if you’ve just resolved to start a healthier diet.
Eight ways to cope with the holidays during a pandemic
For people affected by breast cancer, the holidays can be difficult every year. As experts caution against large events, traveling, and indoor gatherings for the 2020 season, the way we celebrate this year will be different than we are used to, and that can make this time even more upsetting.
Breast cancer treatment during the coronavirus outbreak
Drs. Julie Gralow and Reshma Mahtani explain how people in treatment for breast cancer can balance the known threat of breast cancer against what was known about the potential threat of developing COVID-19 in the first few months of the pandemic.